AGP Executive Report

Drug Safety & Recalls: Unique Pharmaceutical Laboratories voluntarily recalls four lots of cetirizine tablets after potential cross-contamination with ranitidine, warning of serious hypersensitivity and anaphylaxis risk for sensitive patients. Workforce Policy: The AAMC backs Senate HELP Committee action advancing the EMPOWER for Health Act and nursing workforce reauthorization to sustain HRSA training and access programs. Payer Access Rules: New survey data show Medicare Part D and commercial plans increasingly using step therapy, formulary exclusions, prior authorization, and biosimilar preference as IRA rules reshape benefit design. Ophthalmology Costs Beyond the Drug: Anti-VEGF retinal injections drive higher patient spending from travel and lost wages than the medication and visit costs combined. Oncology Trial Safety Signal: Atezolizumab plus consolidative thoracic radiotherapy in extensive-stage small cell lung cancer was stopped early after a rise in fatal adverse events. Pharma Manufacturing & Regulation: FDA launches a pilot to boost US manufacturing of animal drugs, aiming to strengthen domestic supply continuity. Biotech Funding: Crystalys Therapeutics raises $130M Series B to advance its gout drug dotinurad through late-stage testing. AI in Pharma Reality Check: Industry benchmarking finds AI use is uneven and mostly limited to documentation and compliance, with few fully embedded workflows. Generic Drug Tariffs: Trump announces phased zero-to-200% tariffs on imported generics starting after a reprieve, raising major supply-chain and pricing concerns.

Cell Therapy Deal: MaxCyte signed a technology license partnership with Genentech to use its ExPERT GTx platform across cell-engineering, analytics, and cGMP workflows. Bradykinin Angioedema Research: Pharvaris published a comprehensive review in Clinical Reviews in Allergy & Immunology backing bradykinin B2 receptor antagonism as a validated approach for bradykinin-mediated angioedema. AI in Pharma Adoption: A new report warns pharma’s AI spend is outpacing real use at key discovery steps, blaming fragmented data readiness and a “trust gap” between models and bench scientists. GLP-1 Coverage Pressure: Coverage gaps for employer benefits and Medicare are still shaping access to GLP-1s, with early Medicare pilot signals showing many older patients choosing injectables. Childhood Obesity Evidence: A meta-analysis suggests GLP-1 weight-loss injections may help some children with obesity, but only under specialist supervision due to side effects and unknown long-term safety. Clinical Trials Reform: FDA’s Project TrialBlazer aims to speed early trial timelines and bring more studies back to the U.S. Stroke Rehab Tech: Marengo Asia Hospitals launched rTMS to support stroke rehabilitation and neuroplasticity. Lung Cancer Screening Gap: A study finds only ~13% of lung cancer patients met low-dose CT screening criteria, highlighting eligibility and uptake barriers. Policy & Payments: A court ruled manufacturers can’t impose certain 340B rebate models without HHS approval; AHA also weighed in on Medicaid supplemental payments, provider tax rules, and price transparency bills. Tariffs Shake Pharma: Trump’s phased up-to-200% tariff plan for imported generic drugs is roiling markets and raising concerns about feasibility, supply-chain timing, and costs. PE-RADS Standardization: A new PE-RADS v2026 reporting framework is set to standardize CT/MR pulmonary embolism imaging communication across care teams. Neuro Workforce Concern (India): Experts warn rising neurological disorders are colliding with a shortage of neurologists, delaying diagnosis and treatment.

Texas Crackdown on Birth Tourism: Texas Gov. Greg Abbott signed an executive order directing multiple state health and licensing agencies to investigate alleged “birth tourism” schemes and pursue enforcement against providers who advertise, solicit, assist, or facilitate them, framing the activity as fraud and warning that penalties could include license action. Payment for Clinical AI: A new report from the Peterson Health Technology Institute says today’s common reimbursement models don’t properly pay for providers’ growing use of clinical AI, especially more autonomous tools, which could slow adoption. Cyclospora Update: Health officials say the U.S. cyclosporiasis outbreak is “under control,” while Mexico casts doubt on a link to a Taylor Farms facility as investigators continue tracing the source. Diabetes Care Boost from CGM: A study in JAMA Network Open finds primary-care CGM prescriptions for insulin-treated adults meaningfully lower HbA1c and reduce acute care events over time. Oncology & Pharma Moves: Telix dosed the first patient in a phase 3 trial of a CAIX-targeting radiopharmaceutical for relapsed clear cell renal cell carcinoma, while Agios stops a sickle cell drug after phase 2 results didn’t differentiate enough. GLP-1 Legal Fight: Novo Nordisk sued Eli Lilly over “misleading” GLP-1 advertising comparisons, escalating the weight-loss drug rivalry. Clinical Safety & Workforce: Hazelden Betty Ford nurses begin a strike seeking a first contract, and separate reporting highlights how unmanaged clinician AI use raises HIPAA and cybersecurity risks.

GMP & Quality Ops: InstantGMP rolled out agentic AI inside its InstantGMP platform so manufacturers can ask natural-language questions and get cross-module answers on deviations, CAPAs, batch status, and inspection readiness in minutes. FDA & Patient Safety: GE HealthCare recalled certain Optima XR Mobile Digital-Ready radiographic systems after column replacement work may skip safety testing, risking arm drop and potential patient injury. Medicare Access Fight: A Senate vote blocked Democrats’ effort to end the Medicare AI prior authorization pilot (WISeR), keeping the program alive while opponents vow to continue. Public Health Targets: China released its 2026–30 health plan aiming to curb chronic disease and raise life expectancy to 80 by 2030, alongside stronger smoking-cessation goals and expanded fertility/childcare services. Long COVID Treatment Research: UK researchers launched a randomized platform trial testing rivaroxaban, colchicine, and antihistamine-loratidine for persistent post-acute COVID fatigue. Diagnostics & Care Delivery: Radiology Partners named Matt Peterson to lead clinical services, while a study warned many incidental breast masses on emergency chest CTs are missed, delaying cancer diagnosis. Identity Verification in Benefits: Medi Assist integrated Aadhaar Offline Verification into health benefits platforms to reduce paperwork and identity misuse risk. Dengue Vaccine Milestone (India): CDSCO approved Takeda’s Qdenga for ages 4–60, marking India’s first dengue vaccine authorization.

Biomanufacturing Flexibility: WuXi Biologics says it converted a batch pilot line to continuous processing at 100-L scale without building dedicated continuous equipment, using membrane chromatography to lower the usual capital barrier. Value-Based Care Economics: A new open-source playbook from Ten Ten Ten argues independent primary care practices are losing too much shared-savings value to intermediaries instead of reinvesting in care delivery. Controlled Substances Compliance: Guidance highlights that DEA registrations and controlled-substance inventory are the registrant’s legal responsibility—employment contracts can’t override federal rules during practice transitions. AI in Drug Discovery: Bristol Myers Squibb expands its Nvidia compute setup with a DGX SuperPOD to accelerate AI-driven hypothesis generation. Alzheimer’s Access Shift: FDA cleared a subcutaneous starting dose for lecanemab, enabling earlier at-home weekly self-injection for eligible patients. Cyclospora Response: FDA and CDC stress the investigation is ongoing after a false-positive test, while Mexico launches a preventive probe into the lettuce supply chain tied to the outbreak. Workforce Policy: Wisconsin approved an emergency rule allowing qualified RNs to teach clinical courses to ease nursing shortages. Vet Industry Leadership: NVA added two major healthcare leaders to its board, signaling continued expansion in animal health services.

Workforce & Manufacturing Readiness: Ohio is launching a Life Science Training Center with up to $30M to build a statewide pipeline of pharma operators and technicians, aiming to speed hiring and scale biomanufacturing across all 88 counties. Policy for Better Diagnostics: A bipartisan U.S. bill would invest $25M to expand VA access to advanced 4D medical imaging software for veterans’ respiratory care and lung cancer evaluation. Cybersecurity in Healthcare Tech: Craneware says a cyber attack led to theft of some customer and employee data, with the incident contained and authorities notified. GLP-1 Safety Signal: A large study using All of Us data found semaglutide initiation was linked to a lower risk of adult-onset seizure versus other glucose-lowering drugs and SGLT2 inhibitors. Healthcare Access in Remote Areas: Nepal’s Himalaya Eye Hospital Pokhara expanded free eye services across Karnali, reaching thousands through camps, centers, and outpatient care. Medical Infrastructure Investment: Serbia submitted a €110M framework loan to renovate healthcare centers, with disbursements in tranches and repayment options up to 20 years. Drug Innovation & Deals: China reported a “systemic leap” in domestic innovative drug approvals and record out-licensing deal value above $100B in H1. Medtech & Care Delivery: UW Health Kids opened a pediatric interventional radiology suite using GE HealthCare’s Allia Moveo for image-guided procedures. Drug Supply Chain Visibility: Southgate Global launched an Asset Tracking system to improve warehouse and supply chain visibility and reduce shortages and downtime.

Bilateral Health & Pharma Investment: Pakistan and China signed about $1.4B in agreements at a two-day business conference in Islamabad, including deals for local pharmaceutical manufacturing, medical devices, vaccines, and healthcare technology—aimed at technology transfer, fewer import dependencies, and new jobs. Maternal Care Accountability: In the UK, bereaved families tied to Nottingham maternity services are urging the government to strip honours from former NHS leaders after the Ockenden review described “deeply embedded systemic failures.” New Gambling Risk Link: A study finds video game loot boxes are associated with higher problem gambling rates and personal harm, with risks comparable to casino-style gambling. Neurotech for Disability: China’s brain-computer interface startup NeuroXess plans mass production of surface brain chips, targeting spinal cord injury patients and scaling from trials toward broader access. Cancer Precision Updates: NCCN bladder cancer guidance highlights ctDNA MRD use after cystectomy to guide adjuvant immunotherapy decisions. Cholesterol Drug Breakthrough: The FDA approved Merck’s first oral PCSK9 inhibitor (Lipfendra), expanding options beyond injections for LDL lowering. Public Health Equity Warning: A global health analysis argues outbreak response moves slower when diseases hit displacement- and inequality-strained regions, leaving vulnerable communities at greater risk. Community Care on the Ground: A Las Vegas street medicine team is bringing blood pressure checks and medication refills to people experiencing homelessness. Rare Disease Access Pressure (Australia): A report says only a small share of new medicines are subsidised on Australia’s PBS, leaving patients without access to multiple innovative therapies. Peptide Use Concerns (US): A survey reports many clinicians say patients are using unapproved peptides sourced from medspas, compounding pharmacies, and online products. Orphan Drug Policy Fight (Spain): AELMHU asks Spain to exclude orphan and ultra-orphan drugs from a new provision, warning it could harm access and investment incentives. Measles Surge (Pakistan): Sindh reports 53 measles deaths this year amid thousands of suspected and confirmed cases.

Payer Pressure in Eye Care: ASRS research links step therapy for Vabysmo (faricimab) in diabetic macular edema to treatment delays and added burdens for patients and clinics, while another ASRS abstract finds retina-only practices dismiss patients who are often younger, male, and from lower-income areas. Medication Safety at Home: Doctors warn that some medicines can lose strength or become unsafe soon after opening, and “throw it out after a month” isn’t universal—check storage, appearance, and the label. Pediatric Antibiotic Expansion: The FDA accepted Shionogi’s sNDA to expand cefiderocol use to pediatric patients with serious Gram-negative infections, including HABP/VABP and cUTIs, with a PDUFA target of Feb. 23, 2027. Global Pharma Deals: Pakistan and China wrapped a B2B conference with about $850M in agreements, including contracts and MoUs aimed at local vaccine and drug manufacturing. Public Health Alerts: Thailand launched public consultation on a revised surrogacy bill, while Nigeria faces calls to expand health insurance coverage beyond the small share currently insured. Clinical Innovation: A personalized TMS trial for PTSD reported reduced amygdala threat reactivity after scan-guided stimulation.

FDA & Pediatrics: FDA accepted Shionogi’s sNDA to expand cefiderocol (Fetroja) for pediatric Gram-negative infections, aiming to cover children from birth (≥26 weeks gestational age) through <18 for HABP/VABP and cUTIs, with a PDUFA target of Feb. 23, 2027. Cancer Coverage & Care Delivery: A new look at ctDNA MRD testing in bladder cancer highlights payer coverage gaps (only ~40%–50% coverage), forcing appeals and leaving no standard playbook for surveillance testing frequency and how to manage ctDNA-positive to ctDNA-negative conversions. Pediatric Safety Policy: Pakistan’s Paediatric Association urged DRAP to review a ban on 10cc syringes after pediatric HIV cases in Karachi, arguing the devices are essential for NICUs and children’s care. Allergy & Perioperative Risks: Clinicians warn perioperative anaphylaxis can come from underreported exposures like surgical dyes, latex, and chlorhexidine, complicating workups. Ophthalmology Access: ASRS presentations link loss of retina copay assistance to worse outcomes after switching from branded anti-VEGF to bevacizumab, including more anatomic worsening and shorter injection intervals. Mental Health Tech: A personalized TMS trial in PTSD used fMRI-guided targeting of prefrontal areas connected to the amygdala, showing reduced threat reactivity months later. Healthcare Access in Nigeria: Stakeholders say only 5%–8% of Nigerians have health insurance, urging faster enrollment to prevent families from falling into medical debt.

Medicare Drug Pricing: CMS released draft guidance for the 2028 Medicare Drug Price Negotiation cycle, outlining how Part B and Part D drugs will be handled and opening a comment window until Sept. 18. Hospital Safety: A CDC survey in NEJM found healthcare-associated infection prevalence fell in U.S. hospitals in 2023 versus 2015, with pneumonia, surgical-site, and gastrointestinal infections most common. Cybersecurity for Care Delivery: CISA warned that four Microsoft SharePoint vulnerabilities are being exploited, urging hospitals to patch and monitor for unusual activity. Public Health—Cyclospora: CDC says Taco Bell shredded iceberg lettuce in five states is the source of a multistate cyclospora outbreak, with 1,644 reported infections and 94 hospitalizations. Infectious Disease Watch: WHO reported the Bundibugyo Ebola outbreak in DRC has reached 2,124 cases and 828 deaths, with a new lab-confirmed case in a medically evacuated U.S. humanitarian worker. Cardiovascular Screening: A UK cardiologist cautioned that being slim doesn’t protect against high cholesterol and urged regular blood tests. Healthcare Workforce Model: U.S. hospitals are increasingly outsourcing in-person nursing to remote health workers in the Philippines, highlighting a growing staffing workaround. Global Pharma & Manufacturing: Pakistan and China opened a two-day healthcare investment conference focused on co-production of medicines, vaccines, and biotech under CPEC 2.0.

FDA Approval Watch: Novartis’ Fabhalta (ipacopan) gets traditional approval for slowing kidney function decline in adults with primary IgA nephropathy, moving from accelerated approval and carrying an infection-risk note tied to a restricted safety program. Chronic Care Guidance: AASM guidance on combining CBT-I with medications for chronic insomnia aims to close gaps clinicians face when pairing behavioral and drug approaches. Cancer Decision-Making: Updated NCCN guidance for muscle-invasive bladder cancer brings ctDNA molecular residual disease testing into adjuvant planning after radical cystectomy, raising practical questions on timing and payer coverage. Oncology Trial Results: ENDURANCE trial data show no overall survival gain for indefinite vs fixed 2-year lenalidomide maintenance in standard-risk NDMM, suggesting a defined course may spare toxicity. Biopharma Manufacturing: Continuous bioprocessing momentum keeps building, with ICH Q13 cited as a global framework pushing more efficient, scalable production. AI & Safety: Healthcare leaders are urged to tighten AI data security oversight as consumer tools and AI features expand the risk of unauthorized handling of regulated patient information. Public Health: A multistate Cyclospora outbreak linked to Taco Bell lettuce continues, with agencies emphasizing symptoms, testing limits, and prevention. Eye Health & Workforce: A major UK anterior segment dataset (CADMUS) and new optometry training intake highlight research and staffing momentum in vision care.

Federal Grants & Compliance: The American College of Radiology is pushing back on proposed federal changes to grantmaking, warning they could disrupt how radiology and radiation oncology research is reviewed, funded, and terminated, while adding heavier monitoring and compliance burdens. Critical Care Tech Partnerships: Medtronic and Apollo Hospitals in Hyderabad are launching an “ICU of the Future,” a tech-integrated 11-bed unit built to improve real-time monitoring and clinician decision-making. Nursing Home Oversight: CMS is rolling out a nationwide risk-based survey process for high-performing nursing homes, aiming to cut survey time and staffing needs while keeping at least every-15-month coverage. Immigration Rules for Physicians: DHS finalized changes to replace “duration of status” for certain visa holders, including J-1 physician trainees, with fixed admission periods—an issue with potential training impacts. Cholesterol Drug Push: MSD won FDA approval for Lipfendra, a once-daily oral PCSK9 inhibitor to lower LDL-C, positioning it against injectable competitors. Mental Health Innovation: Leiutis Pharmaceuticals’ synthetic CBD oral solution for mild-to-moderate anxiety disorders received CDSCO approval for use with CBT. Radiopharma Funding: AdvanCell raised $315m to expand manufacturing and advance its PSMA-targeted radioligand therapy into phase 3. Public Health & Climate: A review warns climate change could weaken progress against waterborne diseases by altering how pathogens spread, calling for pathogen-specific responses. UK Vaccines: JCVI recommended routine MenB vaccination for all 15-year-olds, with catch-up doses for those who missed earlier shots.

FDA & Lipids: Merck’s Lipfendra (enlicitide) is now FDA-approved as the first oral PCSK9 inhibitor for adults with hypercholesterolemia, cutting LDL-C about 56–59% in Phase 3 trials and offering a daily pill option where PCSK9 drugs were previously injections. Big Pharma Deals: Eli Lilly agreed to buy AtaiBeckley for about $2.8B (up to ~$3.8B with milestones), signaling major mainstream momentum for neuroplastogen/psychedelic-adjacent mental health R&D. Cancer Pipeline: Merck reported pembrolizumab monotherapy improved progression-free survival in frontline dMMR endometrial cancer; other studies highlighted orelabrutinib in treatment-naive CLL/SLL and INT230-6 restarting dosing in a Phase 2 presurgical TNBC trial. Oncology Care & Access: New US data show 5-fraction breast radiotherapy adoption rising fast from 2020–2023, but with persistent insurance-driven gaps. Public Health & Tech: CHAI launched an AI adoption support initiative for local and state public health agencies, while wearable data still struggles to reach clinical workflows. Safety Watch: A Glasgow hospital investigation follows reports of a corrosive chemical used on floors for years. Wellness: Cleveland Clinic spotlights blueberries’ anthocyanin-rich antioxidant benefits for heart, brain, and inflammation.

Policy & Access: Ireland published results from a public consultation on banning commercial sunbeds, with officials saying the issue is complex and will be handled in an evidence-based, proportionate way. Cancer Care: UK doctors warn that heat can worsen antidepressant-related sweating and disrupt sleep, while India’s prostate cancer specialists say rising cases are increasingly coming from smaller towns—but delayed diagnosis remains the biggest problem. Affordability Pressure: A UK consumer alert says shopping around at private health insurance renewals could save up to £1,860 a year, as premiums climb and many people don’t negotiate or switch. Digital Health in Action: Nepal’s toll-free free-bed health portal has surpassed 2,200 people served, with hundreds of hospitals updating availability and even blood information. Pharma & Innovation: EU regulators approved Novo Nordisk’s oral Wegovy for obesity, and Merck plans new HIV pipeline data at AIDS 2026. Healthcare System Rules: The AHA urged CMS and HRSA on 340B and lab regulation changes, warning that proposed administrative burdens and rule shifts could disrupt hospital operations.

FDA Approvals: Celcuity’s Revtorpyk (gedatolisib) won FDA clearance for adults with HR-positive, HER2-negative advanced or metastatic breast cancer without PIK3CA mutations, to be launched late Q3 as a second-line option in combinations with Faslodex and Ibrance. Cancer Trials: ORIC Pharmaceuticals and Bayer started a pivotal Phase 3 trial (Himalayas-1) of rinzimetostat plus darolutamide for mCRPC after abiraterone progression. Neuro/Diagnostics: An AI-driven EEG model improved objective pain-level classification by filtering unreliable training samples, aiming to help patients who can’t communicate. Public Health: A pooled analysis of 11 cohorts linked sugar-sweetened beverages to higher liver cancer subtype risk, while artificially sweetened drinks showed no independent association. Healthcare Policy & Costs: FTC secured a settlement with Caremark to improve PBM practices and unlock up to $8.5B in consumer savings over a decade. Rural Care: Vancouver Coastal Health plans to expand a Transitional Care Unit in Sechelt to free acute beds and support post-hospital recovery. Workforce: MGMA reports practice staff pay gains are cooling as retention pressure shifts from wages to management and role design.

Space Health & Tech: A portable, FDA-cleared X-ray system successfully captured the first diagnostic-quality human images during spaceflight, with independent radiologists rating most extremity images comparable to preflight results. Medicare Payment Pressure: Radiation oncologists and interventional radiology groups are sounding alarms over CMS’s proposed 2027 physician fee schedule, warning of “devastating” cuts that could threaten access and practice viability. Alzheimer’s Diagnostics: At AAIC, blood-based Alzheimer biomarkers—especially p-tau217—were highlighted as clinicians work to fit scalable blood testing into diagnosis and early detection pathways. Drug Discovery Workflow: Sponsored coverage spotlights how connecting “make” and “test” workflows—and easing purification bottlenecks—could speed the DMTA cycle as AI expands compound throughput. Public Health: Namibia declared its cholera outbreak over after more than 28 days with no confirmed cases in affected districts. Diarrhea Outbreak Watch: The CDC is investigating a Cyclospora outbreak with thousands of suspected cases, with experts urging people to avoid certain fresh produce temporarily. Diabetes Support: DESMOND marks 20 years, citing support for more than 800,000 people with type 2 diabetes through structured education and self-management tools. Aged Care Reform: Australia’s aged care inspector-general warned that aged care reform “plumbing” is clashing with the act’s promise, citing co-payments and complex processes that can cause harm. Women & Heat: Health experts say extreme heat can hit women harder due to biology, hormones, and sweating differences, raising risks from dizziness to heat-related illness.